Skip to content

Clinical study on the integrated program of postoperative health care for gastric cancer based on "spleen as the foundation of acquired"(part of randomized controlled trial)

Clinical study on the integrated program of postoperative health care for gastric cancer based on "spleen as the foundation of acquired"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000007
Enrollment
Unknown
Registered
2023-05-08
Start date
2022-04-12
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

control group:Baseline treatment (1) Nutritional supplements: Chinese yam, lily, lotus seed and Coix seed are ground into powder and mixed with protein powder to make nutritional supplement powder. On
treatment group:Baseline treatment + Dioscorea pill plus or minus (decocted in water, twice a day.)

Sponsors

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Tumor patients with definite pathological and cytological diagnosis. (2) The syndrome type of TCM was diagnosed as spleen deficiency syndrome. (3) Patients aged from 18 to 80 years old, regardless of gender. (4) Karnofsky scores =70. (5) no serious diseases of the heart, liver, kidney, hematopoietic system or other factors affecting drug evaluation. (6) Those who can understand the situation of this experiment and have signed the informed consent. (7) Patients with nutritional risk were assessed as having nutritional status.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria. (2) Patients with obvious damage of heart, liver, kidney or hematopoietic function, or mental patients, pregnant or lactating women. (3) Participants in other drug trials. (4) Those who are known to be allergic to this drug or do not take the drug as prescribed or have incomplete information.

Design outcomes

Primary

MeasureTime frame
traditional Chinese medicine syndrome score;

Secondary

MeasureTime frame
abdominal ultrasound scan;vascular endothelial growth factor;carcino-embryonic antigen;Carbohydrate Antigen 199;Carbohydrate Antigen 50;Quality of Life Core Scale;Karnofsky performance status;abdominal computerized tomography scan (CT) or magnetic resonance imaging (MRI);Carbohydrate Antigen 125;fibroenteroscope or barium enema;disease -free-survival;

Countries

China

Contacts

Public ContactHuirong Zhu
zhu_huirong@126.com18916003000

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026